Potenza Leonardo, Giusti Davide, Borelli Eleonora, Colaci Elisabetta, Banchelli Federico, Cuoghi Costantini Riccardo, Forghieri Fabio, Morselli Monica, Bettelli Francesca, Pioli Valeria, Cuoghi Angela, Bresciani Paola, Messerotti Andrea, Gilioli Andrea, Marasca Roberto, Candoni Anna, Cassanelli Luca, Parisotto Angelica, Martini Elia, Morandi Francesco, Bigi Sarah, D'Amico Roberto, Efficace Fabio, Odejide Oreofe, Bruera Eduardo, Zimmermann Camilla, Luppi Mario, Bandieri Elena
Hematology Unit and Chair (L.P., D.G., E.B., E.C., M.M., F.B., V.P., A.C., P.B., A.M., A.G., R.M., A.C., L.C., A.P., E.M., F.M., M.L.), Azienda Ospedaliera Universitaria di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Hematology Unit and Chair (L.P., D.G., E.B., E.C., M.M., F.B., V.P., A.C., P.B., A.M., A.G., R.M., A.C., L.C., A.P., E.M., F.M., M.L.), Azienda Ospedaliera Universitaria di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
J Pain Symptom Manage. 2025 Aug;70(2):121-130.e3. doi: 10.1016/j.jpainsymman.2025.03.029. Epub 2025 Apr 3.
Patients with acute leukemia frequently receive aggressive treatments near the end of life (EOL). Goals-of-care (GOC) conversations may improve EOL quality, yet few studies have investigated their impact in hematological malignancies.
To evaluate sociodemographic and clinical factors associated with GOC conversations and the impact of GOC conversations on EOL care.
A retrospective study was conducted among patients with acute leukemia and high-risk myelodysplastic syndromes, treated over a 15-year period at authors' Institution.
Of 390 patients, 44.4% had GOC conversations. Palliative care specialists documented the first GOC discussion in 157 patients. One hundred and thirty-three (76.9%) patients received GOC conversations within a program of early palliative care (EPC) . In multivariable analysis, age≥60 (OR: 4.85; 95% CI: 2.18-10.78), ≥2 comorbidities (OR: 2.52; 95% CI: 1.03-6.2), non-White race (OR: 7.97; 95% CI: 1.13-56.32), prior allogeneic transplantation (OR: 8.74; 95% CI: 2.09-36.58), and EPC integration (OR: 16.28; 95% CI: 4.21-62.92) were significantly associated with higher likelihood of GOC discussions. Concerning EOL care, GOC conversations were associated with reduced odds of chemotherapy in the last 90 days (OR: 0.41; 95% CI: 0.21-0.79), ICU admission in the last 30 days (OR: 0.20; 95% CI: 0.05-0.85), and in-hospital death (OR: 0.35; 95% CI: 0.18-0.69) .
GOC conversations were infrequently performed and the primary factor that increased their likelihood of occurrence was EPC. When GOC conversations took place, patients experienced higher-quality EOL care. These results support increasing EPC for patients with hematologic malignancies to improve GOC conversations and their overall EOL care and suggest EPC as a prime intervention for trials in this setting.
急性白血病患者在生命末期(EOL)常接受积极治疗。照护目标(GOC)对话可能会改善生命末期的质量,但很少有研究调查其在血液系统恶性肿瘤中的影响。
评估与GOC对话相关的社会人口统计学和临床因素,以及GOC对话对生命末期照护的影响。
对在作者所在机构接受治疗的急性白血病和高危骨髓增生异常综合征患者进行了一项回顾性研究,研究时间跨度为15年。
在390例患者中,44.4%进行了GOC对话。姑息治疗专家记录了157例患者的首次GOC讨论。133例(76.9%)患者在早期姑息治疗(EPC)项目中接受了GOC对话。在多变量分析中,年龄≥60岁(比值比:4.85;95%置信区间:2.18 - 10.78)、合并症≥2种(比值比:2.52;95%置信区间:1.03 - 6.2)、非白人种族(比值比:7.97;95%置信区间:1.13 - 56.32)、既往异体移植(比值比:8.74;95%置信区间:2.09 - 36.58)和EPC整合(比值比:16.28;95%置信区间:4.21 - 62.92)与GOC讨论可能性较高显著相关。关于生命末期照护,GOC对话与过去90天内化疗几率降低(比值比:0.41;95%置信区间:0.21 - 0.79)、过去30天内入住重症监护病房(ICU)几率降低(比值比:0.20;95%置信区间:0.05 - 0.85)以及院内死亡几率降低(比值比:0.35;95%置信区间:0.18 - 0.69)相关。
GOC对话开展较少,增加其发生可能性的主要因素是EPC。当进行GOC对话时,患者接受了更高质量的生命末期照护。这些结果支持为血液系统恶性肿瘤患者增加EPC,以改善GOC对话及其整体生命末期照护,并建议将EPC作为该情况下试验的主要干预措施。